Get the app!
Back to Trades
Sell4

Denali Therapeutics Inc.

DNLI

Total Value
$580.8K
Sales
$580.8K
1 transaction

Company Information

Ticker Symbol
DNLI
CIK
0001714899

Insider Information

Role
President and CEO, Director
Location
SOUTH SAN FRANCISCO, CA

Filing Details

Filing Date
Jan 8, 2026
Transaction Date
Jan 6, 2026
Accession Number
0001724310-26-000004
Form Type
4

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.